Health committee  Yes, just a very quick point. I agree with Dr. Tyrrell. I think there's a certain balkanization of health care records, which does make it very difficult. The e-health scandal in Ontario is an example of that, which I think is a problem that the provincial government is struggli

Health committee  So it's not how much the public pays, but rather how much the drug company pays to basically bring that drug onto the market. Because of the regulatory framework, because of the fears of the drug companies and, to some extent, because of the way that drugs are chosen to go to mar

Health committee  I think it's a real conundrum and it's not the price of drugs, but the cost of bringing a drug to market. So it's not how much—

Health committee  I think one of the things is that universities, particularly smaller universities, are so busy chasing undergraduate enrolment that they are then not able to put funding into basic research. I think that's one of the problems. I think there are a lot of universities where there

Health committee  I have one more thing to say and then I'm done. The last-but-one point on the right-hand side of the screen speaks to some work that was not actually done at Brock University. It was done at the University of Calgary, and the reason I know about it is that my daughter did some o

Health committee  Thank you, and thank you for inviting me to give this talk. I put this slide together from the journal Nature Reviews . I've modified the data so that it's hopefully more understandable to a lay audience. It basically illustrates the cost of bringing a drug to market over the l